|
Patient characteristics |
|
| Characteristics (n = 44) |
|
|
|
|
| Patients |
|
| Male/female, n (%) |
37/7 (84/16) |
| Median age, years (range) |
69 (41–80) |
| Median weight, kg (range) |
74 (58–123) |
|
|
|
| Origin of liver disease, n (%) |
|
| Alcohol abuse |
20 (46) |
| HBV/HCV |
8 (18) |
| NASH |
5 (11) |
| Cryptogenic |
11 (25) |
|
|
|
| Tumor stage, n (%) |
|
| Liver cirrhosis |
37 (84) |
| Child classification A/B/C |
23/9/5 (52/21/11) |
| Okuda stage I/II/III |
13/28/3 (29/64/7) |
| CLIP 0/1–3/4–6 |
2/35/7 (5/79/16) |
|
|
|
| α-FP (ng/ml), n (%) |
|
| < 400 |
29 (66) |
| 400- 10000 |
8 (18) |
| > 10000 |
7 (16) |
|
|
|
| Tumor characteristics, n (%) |
|
| Ascites |
13 (30) |
| Portal vein thrombosis |
14 (32) |
| Multifocal tumor manifestation |
38 (86) |
| Extrahepatic metastases |
9 (21) |
|
|
|
| Previous treatment, n (%) |
|
| (combination possible) |
|
| Surgery |
4 (9) |
| Radiofrequency ablation |
5 (11) |
| Transarterial chemoembolisation |
17 (39) |
| Systemic chemotherapy |
4 (9) |
Dollinger et al. BMC Cancer 2008 8:72 doi:10.1186/1471-2407-8-72 |
|